Medical network - March 8 hemodialysis products meet good news again. On March 7, the state administration of drug safety center review the results of the public trial, for a domestic hemodialysis product takes priority for examination and approval. 

 

The product of the applicant is a chengdu European medical equipment co., LTD. : 

 

Last year, the company has a led project has been listed into the national key research and development program "of biomedical materials research and development and tissue repair alternative" special emphasis, and has been started in October that year project. 

 

This is called "new blood purification materials and wear of artificial kidney key technology research and development and industrialization" projects, the target is to realize the hemodialysis materials, adsorbent and wear the localization of the artificial kidney, got about 18 million yuan of central fiscal subsidies, project period of 4.5 years. 

 

It also has is the second time the drug safety administration issued the preferred examination and approval of the public product, and the time interval of the public for the first time less than a month, also are included in the national key research and development of the hemodialysis products. 

 

 

On February 13th, drug safety administration of the public products for examination and approval of the first priority of hemodialysis 

 

Drug safety administration for examination and approval of priority since the implementation of the New Deal, the profit of the two products are related to hemodialysis. This shows that countries on domestic hemodialysis machine research and development support programs, have entered into the phase of harvest. Next, domestic hemodialysis products on the market for imported products will form the pressure of competition, gradually break the monopoly of imports. 

 

And at the same time, in recent years, under all kinds of policies to guide, hemodialysis market are also showed a trend of explosion. 

 

Encourage policy is one of the scope of hemodialysis was incorporated into a serious illness insurance reimbursement, medical insurance for universal and serious illness, reimbursement ratio is high, a lot of places and policy of free treatment for hemodialysis patients. 

 

It is important to note that even in a health care reform "tough" price adjustment of medical service, the blood dialysis, hemodialysis monitoring with radiotherapy also referred to as "special project" preserved, generally does not make the price adjustment. 

 

In addition, the end of last year, national health development planning commission, issued the basic standards and management norms concerning the hemodialysis center (trial) notice, formal social capital are allowed, the establishment of an independent hemodialysis center, and to encourage to chaining, collectivization development of hemodialysis center. This is mainly in order to meet the needs of the hierarchical diagnosis and treatment, fill the loophole in the grass-roots institutions lack of hemodialysis, but for local companies, and increased public hospital outside another great profit channel, a perfect opportunity to grab market. 

 

And, in fact, despite the health development planning commission documents being released at the end, however, the blue instrument noticed that parker at the local level, it has been a new hemodialysis center is approved, have enterprise first to eat the crab. 

 

On Feb. 27, who in chongqing planning commission party and government, the joint research agreed with the two application for establishing a hemodialysis center, is currently the public stage (March 3 - March 9). 

 

The two hemodialysis center, respectively, "nanshan mountain hemodialysis center" and "jiulongpo district the mountains outside the hemodialysis center", total investment of 11.8 million yuan and 8 million yuan respectively, approved configuration hemodialysis machine 38 and 29, respectively, to carry out diagnosis and treatment subject in addition to blood dialysis room, and internal medicine (kidney disease), clinical laboratory medicine and medical imaging. 

 

Two hemodialysis center application Settings people is the same - chongqing mountain outside the mountain hemodialysis technology co., LTD. The company had previously unknown, but in chongqing has a local well-known blood purification equipment manufacturers - the mountains outside of chongqing blood purification technology co., LTD., already listed on the new three board in August last year. Two mountains outside should be the same, or there is a direct correlation. 

 

It is worth noting that the chongqing municipal planning commission of "instrument of ratification for establishment of medical institution" clear, the two form of system of ownership of hemodialysis center for "profit". This part of the province before and different approval to non-profit hemodialysis center. And profit-making means that can be capitalized operation, can develop their own independent channels of hemodialysis and brands. 

 

In the downstream of hemodialysis services market, in addition to independent hemodialysis center, and with hospital cooperation, acquisition mode. 

 

The shandong xinhua medical to acquire hospitals as the main way, in places such as shandong, hubei, sichuan built a lot of hemodialysis center. Guangdong treasure Wright in advancing bid for hospital strategy, first project - property acquisition of qingyuan guarantee hospital has completed the end of last year. 

 

Shandong weigao as early pioneer, has its hemodialysis center is all over the country, but most of them are with hospital cooperation, the minority is the independence of self-built hemodialysis center. 

 

Public data show that about 2 million patients with end-stage renal disease in our country at present, only 15% received dialysis treatment, a potential huge market space. As domestic hemodialysis products have approved, as more local hemodialysis enterprise layout of the hemodialysis center, under the dual forces upstream and downstream, the next few years, to break the monopoly, and relatively low domestic hemodialysis products to be imported, should be to the outbreak.